The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

“We didn’t pay as much attention as we should have to the experience of our most knowledgeable engineers that have been with ...

"Mistakenly we thought that by just introducing artificial intelligence ... that would produce a high-quality product.” ...

Manhattan's most valuable multifamily opportunities are increasingly defined by scarcity rather than scale. BKREA's $28 ...

The V.I. Public Finance Authority board on Thursday approved a $1.5 million payment to the V.I. Port Authority, following ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies for solid tumors ...

Scope:This Research Topic explores how disruption of epithelial integrity drives the initiation, progression, and treatment response of squamous cell ...